TNK BIOTECH ApS: Financial statements 2014
CVR: 30691911
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
TNK BIOTECH ApS (CVR 30691911) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -8,378 and a net result of DKK -10,712 compared with DKK 74,885 the year before. Equity in the 2014 report amounted to DKK 88,355. The solvency ratio was 58.1%.
- Gross Profit
- DKK -8,378
- Profit/Loss
- DKK -10,712
- Equity
- DKK 88,355
- Total Assets
- DKK 152,011
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -8 t. | -11 t. | 88 t. | - |
| 2013 | - | 269 t. | 75 t. | 99 t. | - |
| 2012 | - | - | - | - | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
TNK BIOTECH ApS has published its annual report for 2013. Gross profit came to DKK 269,188, and the net result was DKK 74,885.
About TNK BIOTECH ApS
TNK BIOTECH ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2007. The company is registered under the industry Investering for egen regning. The company was previously named TNK INVEST ApS. The management consists of Thomas Nitschke Kledal. The company is owned by Thomas Nitschke Kledal. The company has 0 employees (2013). In 2025, the company reported a gross profit of DKK -11,363 and a net result of DKK -17,528 compared with DKK -15,724 the year before. Equity in the 2025 report amounted to DKK -82,154.